Where Technology meets Opportunity in Science and Engineering
Power At your Finger Tips
Click category or weSRCH domain below to read news from each weSRCH domain
High Tech :- Business, Consumer, Displays, IT, Mobile, Photo, Semiconductors
Medicine :- Biology, Biotech/Pharma, Equipment, Imaging, Implants, Practice Mngmnt, Therapy, Veterinary
Green Tech :- Battery & Fuel, Biomass, Environmental, Fossil/Nuclear, Lighting, Solar, Trans, Wind/Water/Geo
Business :- Companies, Entrepreneurial, IP/Law, Leadership & Strategy, Management, Sales & Marketing, Social Innovation

Latest News, Top News, Breaking News

    Total record(s) 1831 , Page No. 1 , Max 20 Records Per Page -
    Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>

    Stem cells from human skin turned into kidney tissue - The Guardian

      The Guardian Scientists in Australia succeed in growing 'organoids' comparable to early stage of a baby's kidneys that have collecting ducts and filtering units called nephons. Image of a mini-kidney formed in a dish from hu ....more | Save |  Share  Email 7th Oct 2015 

    Cell Therapy mulls IPO as regenerative medicine boards EMA fast track - FierceBiotech

      The European Medicines Agency (EMA) has put Cell Therapy's Heartcel on its conditional approval pathway, raising the possibility the allogeneic stem cell therapy could come to market in 2017. And with t ....more | Save |  Share  Email 7th Oct 2015 

    Trade-Ideas: ANI Pharmaceuticals (ANIP) Is Today's "Dead Cat Bounce" Stock - TheStreet.com

      Trade-Ideas LLC identified ANI Pharmaceuticals ( ANIP) as a "dead cat bounce" (down big yesterday but up big today) candidate. In addition to specific proprietary factors, Trade-Ideas iden ....more | Save |  Share  Email 7th Oct 2015 

    Commit To Buy Regeneron Pharmaceuticals At $320, Earn 6.6% Using Options - Nasdaq

      Nasdaq Investors considering a purchase of Regeneron Pharmaceuticals, Inc. (Symbol: REGN) stock, but cautious about paying the going market price of $469.90/share, might benefit from considering selling puts among the alte ....more | Save |  Share  Email 7th Oct 2015 

    The Frustrating Process of Obtaining Expensive Diabetes Supplies - Huffington Post

      Huffington Post If you'll excuse me, before I work on this blog, I have to make a fourth call to my diabetes doctor's office, who was referred to me by my primary care doctor (after waiting until he got the referr ....more | Save |  Share  Email 7th Oct 2015 

    The Alliance for Regenerative Medicine Names 32 Member Representatives as New ... - SYS-CON Media (press release)

      WASHINGTON, DC -- (Marketwired) -- 10/07/15 -- The Alliance for Regenerative Medicine (ARM), the international organization representing the gene therapy, cell therapy and tissue engineerin ....more | Save |  Share  Email 7th Oct 2015 

    US FTC: 'Product-hopping' illegally impedes generic entry - In-PharmaTechnologist.com

      in-PharmaTechnologist.com, Outsourcing-Pharma.com, BioPharma-Reporter.com NEW! Pharmaceutical Technology - Daily. Pharmaceutical Outsourcing - Daily. Biopharmaceutical Development - Daily. Pharmaceutical Techn ....more | Save |  Share  Email 7th Oct 2015 

    Pluristem CEO Zami Aberman Elected to Board of Directors of the Alliance for ... - GlobeNewswire (press release)

      Based in Washington, D.C., ARM promotes research, development, investment and commercialization of regenerative medicine technologies. Pluristem has been a member of ARM for 3 years and has ....more | Save |  Share  Email 7th Oct 2015 

    Noom, NY urgent care network to pilot Samsung S Health for diabetes prevention - MobiHealthNews

      MobiHealthNews New York City-based wellness app maker Noom and CityMD, a network of urgent care medical centers in and around New York City, are launching a pilot for people who are at risk for Type 2 diabete ....more | Save |  Share  Email 7th Oct 2015 

    Healthcare Movers to Watch: AbbVie Inc (NYSE:ABBV), Zoetis Inc (NYSE:ZTS ... - Wsnews4investors

      ... provide new insights into the treatment of severe pediatric chronic plaque psoriasis with adalimumab; and explore psoriasis and psoriatic arthritis patient beliefs, concerns, attitudes and adherence towa ....more | Save |  Share  Email 7th Oct 2015 

    Novel test could predict teens' later-life heart disease, diabetes risk - Medical News Today

      Medical News Today Heart disease is the leading cause of death for men and women in the US, killing around 610,000 people every year. Now, researchers have developed a test that they say can predict future h ....more | Save |  Share  Email 7th Oct 2015 

    Growing demand for vegetarian capsules despite their cost, says Capsugel - In-PharmaTechnologist.com

      In-PharmaTechnologist.com Vieceli's comments come as Capsugel rolls out a new offering for its nutrition customers, combining its vegetarian capsule platform with its liquid-fill technology. While th ....more | Save |  Share  Email 7th Oct 2015 

    Rich Pharmaceuticals Retains Theradex Systems To Finalize Investigational New ... - PR Newswire (press release)

      BEVERLY HILLS, Calif., Oct. 7, 2015 /PRNewswire/ -- Rich Pharmaceuticals, Inc. (OTCPK: RCHA) ("Rich" or the "Company") announced today it has entered into an agreement wit ....more | Save |  Share  Email 7th Oct 2015 

    IBD: Anti-TNF Drugs Tied to Risk for Demyelinating Diseases - Medscape

      Findings from a Danish population-based study suggest a twofold increased relative risk for central demyelinating diseases in patients with inflammatory bowel disease (IBD) who receive tumor necrosis factor (TNF) inhibito ....more | Save |  Share  Email 7th Oct 2015 

    ContraVir Pharmaceuticals, Inc. Pricing Underwritten Public Offering Of Common ... - MarketWatch

      TheStreet.com EDISON, N.J., Oct. 7, 2015 /PRNewswire/ -- ContraVir Pharmaceuticals, Inc. CTRV, -21.78% ("ContraVir" or the "Company"), a biopharmaceutical company focused on the developme ....more | Save |  Share  Email 7th Oct 2015 

    International diabetes research knowledge portal opens to public, scientists - National Institutes of Health (press release)

      A product of the Accelerating Medicines Partnership (AMP) for type 2 diabetes, the portal is aimed at advancing type 2 diabetes research and treatment, and will include data from ....more | Save |  Share  Email 7th Oct 2015 

    Rotation Well Timed for Funds Selling Biotech to Buy Energy - Bloomberg

      Bloomberg They're selling health-care stocks and buying energy faster than any other industries, according to research from FBN Securities. Data on the rotation came as a month-old bear market in biotechnology stocks ....more | Save |  Share  Email 7th Oct 2015 

    Biotech's Bloodbath Is Ridiculous; Here's Why - Motley Fool

      Motley Fool The odd and perhaps ridiculous part of biotech's dramatic downturn is that it has nothing to do with the industry's fundamentals. In fact, many bellwether companies such as Celgene (NASDAQ:CELG) and Gilead Sciences ( ....more | Save |  Share  Email 7th Oct 2015 

    Why Merrill Lynch Now Favors Large Cap Leaders in Biotech - 24/7 Wall St.

      24/7 Wall St. Since the peak of the biotech index in late July, the industry has dropped a staggering 24% through the end of the third quarter, versus the 10% drop in the S&P 500. There are numerous reasons why, not the least ....more | Save |  Share  Email 7th Oct 2015 

    Type of weight loss surgery matters for diabetes remission - Fox News

      Fox News The researchers studied 569 obese patients with type 2 diabetes who had different types of weight-loss operations and 1,881 similar diabetics who didn't have surgery. Altogether, the surgical patients had an al ....more | Save |  Share  Email 7th Oct 2015 
    Total record(s) 1831 , Page No. 1 , Max 20 Records Per Page -
    Page Nos. 1 2 3 4 5 6 7 8 9 10 .... Next >>